By Staff
Tuesday, March 19, 2024 12:15 AM
DELRAY BEACH, Fla.—
Now Optics, parent company of eyecare retail brand
Stanton Optical, has announced its partnership with Scout Onward, a leading athlete search agency, to recruit talented executive team members from sporting backgrounds.
By Staff
Sunday, March 17, 2024 12:18 AM
WALTHAM, Mass.—
Apellis Pharmaceuticals, Inc. (APLS) has appointed leading retina specialist Philip Ferrone, MD, as chief medical retina advisor. “Phil is globally renowned for his leadership in retina, including as a past president of the
American Society of Retina Specialists (ASRS), so we are delighted to welcome him to the Apellis team,” said Caroline Baumal, MD, chief medical officer, Apellis. “Phil has extensive expertise in retina research and patient care, which will be invaluable as we continue to bring Syfovre to patients with geographic atrophy (GA) and advance our retina pipeline.”
By Staff
Wednesday, March 13, 2024 12:21 AM
SAN RAMON, Calif.—
The Wavefront Congress, a convergence of global experts and thought leaders in optical sciences and wavefront technologies for eyecare, has recognized Arthur Bradley, PhD, research fellow at
CooperVision, as a 2024 Luminary for his outstanding contributions to the optometry field for more than four decades. The honor was awarded to him during the Congress, which drew more than 100 optical scientists, clinicians, surgeons and corporate scientists from around the world to Houston, Texas.
By Staff
Monday, March 11, 2024 12:15 AM
KANSAS CITY, Mo.—
Vital Tears, a leader in the development and delivery of autologous serum tears, has announced the appointment of Joseph Tauber, MD, as its chief medical officer (CMO).
By Staff
Wednesday, March 6, 2024 12:33 AM
SABAE, Japan—Eyewear manufacturer
Charmant Group has announced the appointment of Koji Horikawa to the role of president and CEO. Previously executive managing director, Horikawa was approved as the new president and chief executive officer by the shareholder meeting on February 29, 2024. Horikawa is the son of Kaoru Horikawa, founder of Charmant Group. Horikawa began his career in Charmant’s Japanese domestic division 34 years ago, and played a pivotal role in overseeing Chinese manufacturing divisions and product planning while working in China and Hong Kong.
By Staff
Monday, March 4, 2024 12:18 AM
MANSFIELD, Mass.—
Hilco Vision has announced a key addition in its sales leadership. Stuart Jolly has been named the head of sales, Americas – optical & retail division, effective today.
By Staff
Monday, February 26, 2024 12:21 AM
CALGARY, Alberta—
CSI Dry Eye Software, an emerging artificial intelligence (AI) dry eye software company pioneering AI in dry eye diagnostics and treatment recommendations, announced that it has appointed Trudi Charest as chief sales officer.
By Staff
Friday, February 23, 2024 12:24 AM
BEDFORD, Mass.—
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of therapies for diseases and conditions of the eye, has announced board of directors and leadership updates. Pravin U. Dugel, MD has been named executive chairman, and Jeffrey S. Heier, MD, Peter K. Kaiser, MD, and Sanjay Nayak, MBBS, PhD have been appointed to the ocular management team as chief scientific officer, medical director, and chief strategy officer, respectively.
By Staff
Friday, February 23, 2024 12:15 AM
SAN CARLOS, Calif.—
XP Health, a company dedicated to democratizing vision care with a digital-first vision benefits platform, announced a new partnership with Bell Bank and the addition of new chief marketing officer Cynthia Spitalny to grow its leadership roster.
By Staff
Thursday, February 22, 2024 12:15 AM
MELBOURNE, Australia—
Opthea Limited, a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced the appointment of Arshad M. Khanani, MD, MA, FASRS, as chief medical advisor.
By Staff
Tuesday, February 20, 2024 12:24 AM
BEDFORD, Mass.—
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced the appointment of Steve Meyers as chief commercial officer. Meyers has over 20 years of commercial experience, including several buy and bill, specialty pharmacy and innovative technology product launches in highly competitive markets.
By Staff
Tuesday, February 20, 2024 12:15 AM
FARMINGTON HILLS, Mich.—
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, announced the appointments of Ash Jayagopal, Ph.D., MBA as chief scientific and development officer, and Nirav Jhaveri, CFA, MBA as chief financial officer.
By Staff
Friday, February 16, 2024 12:21 AM
CHARENTON-LE-PONT, France—
EssilorLuxottica's board of directors has decided to propose the reappointment of all current directors to the next annual general meeting to be held on April 30, 2024.
By Staff
Thursday, February 15, 2024 12:15 AM
CARLSBAD, Calif.—
Bollé Safety is continuing its efforts to expand its presence in the North American market with additional key appointments, most recently announcing the appointment of Ellena Wong to the position of VP of sales for North America and Latin America markets.
By Staff
Monday, February 12, 2024 12:15 AM
DULUTH, Ga.—
National Vision Holdings, Inc. announced the appointment of Susan O’Farrell to its board of directors and as a member of its audit committee. O’Farrell is an accomplished financial expert with over 35 years of executive and senior leadership experiene.